Perrigo Company plc Form 8-K Summary
Business Context and Reporting Period
Perrigo Company plc (PRGO), incorporated in Ireland, filed this Current Report on August 8, 2019. The filing announces the release of earnings results for the second quarter ended June 29, 2019. The detailed financial data is contained in the attached press release (Exhibit 99.1), which is not included in the text of this 8-K.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It confirms that the Company reports both GAAP and non-GAAP financial measures. Non-GAAP measures exclude items such as impairment charges, amortization, restructuring charges, and acquisition-related costs to highlight underlying operational trends. The Company also discloses adjusted net sales excluding the infant foods product line and animal health business.
Material Changes and Adjustments
The filing outlines the specific adjustments made to reported results for the three months ended June 29, 2019, compared to the prior year period. These adjustments include:
- Amortization expense related to acquired intangible assets.
- Changes in financial assets and losses on investment securities.
- Acquisition and integration-related charges and contingent consideration adjustments.
- Impairment, restructuring, and separation/reorganization expenses.
- Unusual litigation and gains/losses on divestitures.
- Operating results attributable to held-for-sale businesses.
- Foreign currency translation movements.
- Net sales from animal health and infant foods segments.
- Non-GAAP tax adjustments.
Guidance, Outlook, and Management Commentary
Management utilizes non-GAAP measures for planning, forecasting, and evaluating segment performance. These metrics are also used as factors in determining compensation. The filing states that these measures facilitate comparability with peer companies and competitors. No specific forward-looking guidance, risk factors, or contingencies are detailed within the text of this 8-K; investors are directed to the attached press release for further commentary.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2019 revenue, earnings per share, and cash flow figures.
- Verify the magnitude of non-GAAP adjustments, particularly regarding restructuring and impairment charges.
- Confirm the impact of excluding infant foods and animal health sales on reported growth rates.
- Assess the constant currency growth metrics provided in the full earnings release.